David Parke, CEO for the American Academy of Ophthalmology, speaks to the audience of the 5th Annual Ophthalmology Innovation Summit @ AAO, about the importance, benefits and overall successes surrounding the use of clinical registries, namely the IRIS Registry. Highlighting the value proposition for ophthalmologists, David shares the Academy’s hope for the registry to reduce variation, promote loyalty to best practices, and to improve the processes and outcomes surrounding patient care.
David W. Parke, MD II
Dr. Parke is CEO of the American Academy of Ophthalmology. Prior to assuming this role, he served for 17 years as Ophthalmology Chair at the University of Oklahoma.